Back
Janux Therapeutics Stock Price Chart
Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
JANX
Janux Therapeutics
Last Price:
66.94
Seasonality Move:
133.13%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
Janux Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.16 | Buy |
| 20-day SMA: | 50.4 | Buy |
| 50-day SMA: | 49.88 | Buy |
| 200-day SMA: | 44.87 | Buy |
| 8-day EMA: | 49.16 | Buy |
| 20-day EMA: | 49.72 | Buy |
| 50-day EMA: | 49.41 | Buy |
| 200-day EMA: | 41.75 | Buy |
Janux Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 63.62 | Buy |
| Chaikin Money Flow: | -6955717 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.07 - 55.53) | Buy |
| Bollinger Bands (100): | (41.63 - 51.75) | Buy |
Janux Therapeutics Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 59.86 while JANX 8-day simple moving average is 48.16, which is a Buy signal.
- The stock price of JANX is 59.86 while Janux Therapeutics 20-day SMA is 50.40, which makes it a Buy.
- Janux Therapeutics 50-day simple moving average is 49.88 while JANX share price is 59.86, making it a Buy technically.
- JANX stock price is 59.86 and Janux Therapeutics 200-day simple moving average is 44.87, creating a Buy signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a Sell
The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
3.14B
Price in USD:
59.86
Share Volume:
7.67M
Janux Therapeutics 52-Week Range
52-Week High:
71.25
52-Week Low:
7.79
Sell
34
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?
The Janux Therapeutics stock price is 59.86 USD today. -
Will JANX stock go up or go down?
Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Janux Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
- Janux Therapeutics share price is 59.86 while JANX 8-day exponential moving average is 49.16, which is a Buy signal.
- The stock price of JANX is 59.86 while Janux Therapeutics 20-day EMA is 49.72, which makes it a Buy.
- Janux Therapeutics 50-day exponential moving average is 49.41 while JANX share price is 59.86, making it a Buy technically.
- JANX stock price is 59.86 and Janux Therapeutics 200-day simple moving average is 41.75, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
- JANX Moving Average Covergence Divergence (MACD) indicator is -0.63, suggesting Janux Therapeutics is a Sell
- Janux Therapeutics Relative Strength Index (RSI) is 63.62, which suggest Janux Therapeutics is overbought
- The Bollinger Bands (25) for Janux Therapeutics is (47.07 - 55.53), which suggest Janux Therapeutics is a Buy
- The Bollinger Bands (100) for Janux Therapeutics is (41.63 - 51.75), which suggest Janux Therapeutics is a Buy
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.